chr17-19337749-C-G

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 4P and 5B. PVS1_StrongBS1_SupportingBS2

The NM_001321218.2(B9D1):​c.473-1G>C variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00245 in 1,534,642 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.011 ( 23 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 30 hom. )

Consequence

B9D1
NM_001321218.2 splice_acceptor, intron

Scores

5
Splicing: ADA: 0.00006013
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1B:4

Conservation

PhyloP100: 0.267
Variant links:
Genes affected
B9D1 (HGNC:24123): (B9 domain containing 1) This gene encodes a B9 domain-containing protein, one of several that are involved in ciliogenesis. Alterations in expression of this gene have been found in a family with Meckel syndrome. Meckel syndrome has been associated with at least six different genes. This gene is located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Mar 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 6.0958085 fraction of the gene.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0107 (1625/152298) while in subpopulation AFR AF = 0.0355 (1476/41552). AF 95% confidence interval is 0.034. There are 23 homozygotes in GnomAd4. There are 748 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 23 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
B9D1NM_001321218.2 linkc.473-1G>C splice_acceptor_variant, intron_variant Intron 6 of 6 NP_001308147.1 Q9UPM9
B9D1NM_001321219.2 linkc.405-1G>C splice_acceptor_variant, intron_variant Intron 5 of 5 NP_001308148.1 Q9UPM9A0A6Q8PFJ7
B9D1NM_001368769.2 linkc.113-1G>C splice_acceptor_variant, intron_variant Intron 6 of 6 NP_001355698.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
B9D1ENST00000671102.1 linkc.536-1G>C splice_acceptor_variant, intron_variant Intron 7 of 7 ENSP00000499690.1 A0A590UK40
B9D1ENST00000675510.1 linkc.405-1G>C splice_acceptor_variant, intron_variant Intron 5 of 5 ENSP00000501817.1 A0A6Q8PFJ7
B9D1ENST00000674596.1 linkc.303-1G>C splice_acceptor_variant, intron_variant Intron 7 of 7 ENSP00000501877.1 A0A6Q8PFN7
B9D1ENST00000582857.2 linkc.113-1G>C splice_acceptor_variant, intron_variant Intron 6 of 6 4 ENSP00000463165.2 J3QKN6

Frequencies

GnomAD3 genomes
AF:
0.0106
AC:
1618
AN:
152180
Hom.:
23
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0355
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00478
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.000617
Gnomad OTH
AF:
0.0105
GnomAD2 exomes
AF:
0.00284
AC:
382
AN:
134390
AF XY:
0.00201
show subpopulations
Gnomad AFR exome
AF:
0.0378
Gnomad AMR exome
AF:
0.00303
Gnomad ASJ exome
AF:
0.00157
Gnomad EAS exome
AF:
0.0000952
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000720
Gnomad OTH exome
AF:
0.00338
GnomAD4 exome
AF:
0.00154
AC:
2135
AN:
1382344
Hom.:
30
Cov.:
31
AF XY:
0.00134
AC XY:
914
AN XY:
682074
show subpopulations
Gnomad4 AFR exome
AF:
0.0399
AC:
1260
AN:
31558
Gnomad4 AMR exome
AF:
0.00350
AC:
125
AN:
35688
Gnomad4 ASJ exome
AF:
0.00139
AC:
35
AN:
25154
Gnomad4 EAS exome
AF:
0.0000280
AC:
1
AN:
35716
Gnomad4 SAS exome
AF:
0.0000884
AC:
7
AN:
79204
Gnomad4 FIN exome
AF:
0.00
AC:
0
AN:
33780
Gnomad4 NFE exome
AF:
0.000410
AC:
442
AN:
1077728
Gnomad4 Remaining exome
AF:
0.00379
AC:
219
AN:
57850
Heterozygous variant carriers
0
96
192
287
383
479
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0107
AC:
1625
AN:
152298
Hom.:
23
Cov.:
32
AF XY:
0.0100
AC XY:
748
AN XY:
74460
show subpopulations
Gnomad4 AFR
AF:
0.0355
AC:
0.0355218
AN:
0.0355218
Gnomad4 AMR
AF:
0.00477
AC:
0.00476999
AN:
0.00476999
Gnomad4 ASJ
AF:
0.00144
AC:
0.00144175
AN:
0.00144175
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.000207
AC:
0.000206868
AN:
0.000206868
Gnomad4 FIN
AF:
0.00
AC:
0
AN:
0
Gnomad4 NFE
AF:
0.000617
AC:
0.000617338
AN:
0.000617338
Gnomad4 OTH
AF:
0.0104
AC:
0.010397
AN:
0.010397
Heterozygous variant carriers
0
77
154
232
309
386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00581
Hom.:
2
Bravo
AF:
0.0123
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000778
AC:
3
ExAC
AF:
0.00221
AC:
38
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 31, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 23, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Joubert syndrome 27 Pathogenic:1
Sep 26, 2019
New York Genome Center
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Dec 18, 2023
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.473-1G>C variant in B9D1 is classified as benign because it has been identified in 3.5% (1469/41430) of African chromosomes by gnomAD (http://gnomad.broadinstitute.org, v.3.1.2). ACMG/AMP Criteria applied: BA1. -

B9D1-related disorder Benign:1
Jun 05, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.77
T
BayesDel_noAF
Benign
-0.85
CADD
Benign
7.8
DANN
Benign
0.52
FATHMM_MKL
Benign
0.096
N
GERP RS
0.64
Mutation Taster
=100/0
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000060
dbscSNV1_RF
Benign
0.0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs73980009; hg19: chr17-19241062; API